THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Sanofi seeks efficiencies with new model

Debasish Roychowdhury of Sanofi-Aventis says the cancer unit will focus on fewer drugs that have greater potential for success. Debasish Roychowdhury of Sanofi-Aventis says the cancer unit will focus on fewer drugs that have greater potential for success.
By Kelli Whitlock Burton
Globe Correspondent / August 16, 2010

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

The placement of a joint headquarters of Sanofi-Aventis SA’s new cancer research unit in Cambridge, announced last month, marks a turning point for the world’s third-largest pharmaceutical company. (Full article: 903 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass